MEDAVAIL HOLDINGS INC's ticker is MDVL and the CUSIP is 58406B103. A total of 26 filers reported holding MEDAVAIL HOLDINGS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 2.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3,735 | -14.5% | 15,237 | 0.0% | 0.00% | -100.0% |
| Q1 2023 | $4,367 | -4.4% | 15,237 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $4,568 | -61.9% | 15,237 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $12,000 | -47.8% | 15,237 | 0.0% | 0.00% | -33.3% |
| Q2 2022 | $23,000 | +53.3% | 15,237 | 0.0% | 0.00% | +200.0% |
| Q1 2022 | $15,000 | -28.6% | 15,237 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $21,000 | -52.3% | 15,237 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $44,000 | -76.5% | 15,237 | 0.0% | 0.00% | -73.3% |
| Q2 2021 | $187,000 | -12.2% | 15,237 | 0.0% | 0.02% | -11.8% |
| Q1 2021 | $213,000 | -7.0% | 15,237 | 0.0% | 0.02% | -10.5% |
| Q4 2020 | $229,000 | – | 15,237 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG-WTT Global Life Science Capital Partners GP Ltd | 3,885,951 | $47,603,000 | 92.00% |
| Ally Bridge Group (NY) LLC | 2,920,780 | $35,780,000 | 8.89% |
| Redmile Group, LLC | 11,724,726 | $143,628,000 | 2.12% |
| CIGNA INVESTMENTS INC /NEW | 2,389,478 | $29,271,000 | 2.09% |
| Endurant Capital Management LP | 292,196 | $3,579,000 | 0.98% |
| Northern Right Capital Management, L.P. | 150,000 | $1,838,000 | 0.54% |
| PURA VIDA INVESTMENTS, LLC | 1,362,384 | $16,689,000 | 0.52% |
| Monashee Investment Management LLC | 230,568 | $2,824,000 | 0.34% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,142,552 | $13,996,000 | 0.25% |
| Maven Securities LTD | 415,119 | $4,909,000 | 0.20% |